⌘K

Login Start Free

Home/Filings/4/0001628280-22-005791

4//SEC Filing

Kelemen Vicki 4

Accession 0001628280-22-005791

CIK 0001213037other

View on SEC.gov Company Profile

Filed

Mar 9, 7:00 PM ET

Accepted

Mar 10, 6:40 PM ET

Size

5.4 KB

Accession

0001628280-22-005791

Insider Transaction Report

Form 4

Period: 2022-03-09

Cardiff Oncology, Inc.CRDF

Exec. VP and COO

Transactions

Award
Stock Options
2022-03-09+170,016→ 572,784 total
Exercise: $2.50Exp: 2032-03-09→ Common Stock (170,016 underlying)

Footnotes (1)

[F1]42,504 vest on 3/09/2023. 3,542 vest monthly for 36 months beginning on 4/09/2023 through 3/09/2026.

Documents

1 file

4
wf-form4_164695558683169.xmlPrimary
FORM 4

Issuer

Cardiff Oncology, Inc.

CIK 0001213037

Entity typeother

Related Parties

1

filerCIK 0001815809

Filing Metadata

Form type: 4
Filed: Mar 9, 7:00 PM ET
Accepted: Mar 10, 6:40 PM ET
Size: 5.4 KB

View on SEC.gov